查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2153465

全球胚胎著床前基因檢測市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Preimplantation Genetic Testing Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 177 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球胚胎著床前遺傳學檢測（PGT）市場預計將從2025年的10.2151億美元成長到2034年的25.8776億美元，2026年至2034年的複合年成長率（CAGR）為10.88%。全球胚胎著床前市場快速擴張主要得益於輔助生殖技術的進步和廣泛應用。 PGT應用於胚胎著床前（IVF）過程中，用於在胚胎胚胎著床前篩檢是否有遺傳異常。這一過程有助於提高妊娠成功率並降低遺傳疾病的風險。

推動這一市場發展的主要動力是全球遺傳疾病和不孕症問題的日益普遍。隨著人們對基因篩檢的認知不斷提高，越來越多的患者選擇先進的輔助生殖技術。此外，基因測序和基因分析技術的進步也提高了胚胎植入前遺傳學檢測（PGT）的準確性和可靠性。

未來，隨著生殖醫學的進步，胚胎著床前遺傳學檢測（PGT）市場預計將顯著成長。對個人化生殖醫學日益成長的需求以及體外受精成功率的提高將推動市場成長。遺傳學和生殖生物學領域的持續研究有望為先進的胚胎篩檢技術創造新的機會。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節對市場進行了清晰的說明，包括關鍵定義、分類以及當前行業格局的概述。

市場動態：對影響市場成長的主要促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分根據產品類型、應用、最終用戶和地區將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業進行了詳細評估，包括其市場定位、產品系列、策略舉措和財務表現。這有助於深入了解競爭趨勢和主要參與者所採取的策略。

市場預測：本部分提供基於數據的市場規模和成長模式預測，預測期為特定時期。它綜合考慮了歷史趨勢、當前市場狀況和定量分析，以識別未來預期趨勢。

區域分析：這包括對主要地理區域的市場表現進行全面檢驗，確定高成長地區和區域趨勢，以更深入地了解區域市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的報告客製化服務，以滿足您的特定需求。這包括額外的細分、國家/地區分析、競爭對手分析、客製化資料點或針對特定細分市場的洞察，以更好地支援您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章：全球胚胎著床前基因檢測市場：依類型分類

  • 市場分析、洞察與預測
  • 染色體異常
  • 非整倍體
  • X連鎖疾病
  • 單基因疾病
  • HLA型檢測
  • 性別選擇
  • 其他

第5章 全球胚胎著床前基因檢測市場：依最終用戶分類

  • 市場分析、洞察與預測
  • 診斷檢查室
  • 醫院
  • 診所
  • 其他

第6章 全球胚胎著床前基因檢測市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 中國
    • 日本
    • 韓國
    • 印度
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第7章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第8章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • CooperSurgical
    • Illumina
    • Natera
    • Vitrolife
    • Igenomix
    • Fulgent Genetics
    • Eurofins Scientific
    • Genomic Prediction
    • Reproductive Genetics Institute
    • Natera/Parental Embryo Screening
    • Juno Genetics
    • Igenomix/Vitrolife
    • GenEmbryomics
    • CooperGenomics
    • EvolveGene
    • Juno Genomics
    • LifeView
    • Genesis Genetics
    • Progenesis
    • Reprogenetics
簡介目錄
Product Code: VMR11212794

The global preimplantation genetic testing market size is expected to reach USD 2587.76 Million in 2034 from USD 1021.51 Million in 2025, growing at a CAGR of 10.88% during 2026-2034.The global preimplantation genetic testing market is growing rapidly as assisted reproductive technologies become more advanced and widely adopted. Preimplantation genetic testing (PGT) is used during in vitro fertilization (IVF) to screen embryos for genetic abnormalities before implantation. This process helps improve the chances of a successful pregnancy and reduces the risk of genetic disorders.

A major driver of the market is the increasing prevalence of genetic diseases and infertility issues among couples worldwide. As awareness of genetic screening increases, more patients are opting for advanced reproductive technologies. Additionally, improvements in genomic sequencing and genetic analysis technologies have made PGT more accurate and reliable.

Looking ahead, the preimplantation genetic testing market is expected to expand significantly as reproductive medicine continues to advance. The growing demand for personalized reproductive healthcare and improved IVF success rates will support market growth. Ongoing research in genetics and reproductive biology will likely create new opportunities for advanced embryo screening technologies.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Type

  • Chromosomal Abnormalities
  • Aneuploidy
  • X-Linked Diseases
  • Single Gene Disorders
  • Hla Typing
  • Gender Selection
  • Others

By End User

  • Diagnostic Laboratories
  • Hospitals
  • Clinics
  • Others

COMPANIES PROFILED

  • CooperSurgical, Illumina, Natera, Vitrolife, Igenomix, Fulgent Genetics, Eurofins Scientific, Genomic Prediction, Reproductive Genetics Institute, Natera/Parental Embryo Screening, Juno Genetics, Igenomix/Vitrolife, GenEmbryomics, CooperGenomics, EvolveGene, Juno Genomics, LifeView, Genesis Genetics, Progenesis, Reprogenetics

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET: BY TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Type
  • 4.2. Chromosomal Abnormalities Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Aneuploidy Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. X-Linked Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Single Gene Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.6. Hla Typing Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.7. Gender Selection Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.8. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET: BY END USER 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast End User
  • 5.2. Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET: BY REGION 2022-2034 (USD MN)

  • 6.1. Regional Outlook
  • 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.2.1 By Type
    • 6.2.2 By End User
    • 6.2.3 United States
    • 6.2.4 Canada
    • 6.2.5 Mexico
  • 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.3.1 By Type
    • 6.3.2 By End User
    • 6.3.3 United Kingdom
    • 6.3.4 France
    • 6.3.5 Germany
    • 6.3.6 Italy
    • 6.3.7 Spain
    • 6.3.8 Russia
    • 6.3.9 Rest Of Europe
  • 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.4.1 By Type
    • 6.4.2 By End User
    • 6.4.3 China
    • 6.4.4 Japan
    • 6.4.5 South Korea
    • 6.4.6 India
    • 6.4.7 Australia
    • 6.4.8 South East Asia
    • 6.4.9 Rest Of Asia Pacific
  • 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.5.1 By Type
    • 6.5.2 By End User
    • 6.5.3 Brazil
    • 6.5.4 Argentina
    • 6.5.5 Peru
    • 6.5.6 Chile
    • 6.5.7 Rest of Latin America
  • 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.6.1 By Type
    • 6.6.2 By End User
    • 6.6.3 Saudi Arabia
    • 6.6.4 UAE
    • 6.6.5 Israel
    • 6.6.6 South Africa
    • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

  • 7.1. Recent Developments
  • 7.2. Company Categorization
  • 7.3. Supply Chain & Channel Partners (based on availability)
  • 7.4. Market Share & Positioning Analysis (based on availability)
  • 7.5. Vendor Landscape (based on availability)
  • 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL PREIMPLANTATION GENETIC TESTING INDUSTRY

  • 8.1. Top Companies Market Share Analysis
  • 8.2. Company Profiles
    • 8.2.1 CooperSurgical
    • 8.2.2 Illumina
    • 8.2.3 Natera
    • 8.2.4 Vitrolife
    • 8.2.5 Igenomix
    • 8.2.6 Fulgent Genetics
    • 8.2.7 Eurofins Scientific
    • 8.2.8 Genomic Prediction
    • 8.2.9 Reproductive Genetics Institute
    • 8.2.10 Natera/Parental Embryo Screening
    • 8.2.11 Juno Genetics
    • 8.2.12 Igenomix/Vitrolife
    • 8.2.13 GenEmbryomics
    • 8.2.14 CooperGenomics
    • 8.2.15 EvolveGene
    • 8.2.16 Juno Genomics
    • 8.2.17 LifeView
    • 8.2.18 Genesis Genetics
    • 8.2.19 Progenesis
    • 8.2.20 Reprogenetics